View in EDS

A systematic approach to develop and characterize a compositionally equivalent buprenorphine in situ forming implant (Sublocade®).

Saved in:
Bibliographic Details
Title: A systematic approach to develop and characterize a compositionally equivalent buprenorphine in situ forming implant (Sublocade®).
Authors: Poudel S; Department of Pharmaceutics, Virginia Commonwealth University, Richmond, VA 23298, USA., Pangeni R; Department of Pharmaceutics, Virginia Commonwealth University, Richmond, VA 23298, USA., Huo Z; Department of Chemical engineering, Virginia Polytechnic Institute and State University, Blacksburg, VA 24061, USA., Farkas D; Department of Mechanical and Nuclear Engineering, Virginia Commonwealth University, Richmond, VA 23220, USA., Gulec S; Materials Characterization, Anton Paar Inc., Richmond, VA 23298, USA., Zhang Q; Office of Research and Standards, Office of Generic Drugs, CDER, U.S. Food and Drug Administration, Silver Springs, MD 20993, USA., Lasaosa M; Department of Pharmaceutics, Virginia Commonwealth University, Richmond, VA 23298, USA., Tong R; Department of Chemical engineering, Virginia Polytechnic Institute and State University, Blacksburg, VA 24061, USA., Moeller FG; Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA 23298, USA., Li Q; Office of Research and Standards, Office of Generic Drugs, CDER, U.S. Food and Drug Administration, Silver Springs, MD 20993, USA., Wang Y; Office of Research and Standards, Office of Generic Drugs, CDER, U.S. Food and Drug Administration, Silver Springs, MD 20993, USA., Qin B; Office of Research and Standards, Office of Generic Drugs, CDER, U.S. Food and Drug Administration, Silver Springs, MD 20993, USA., Halquist MS; Department of Pharmaceutics, Virginia Commonwealth University, Richmond, VA 23298, USA., Xu Q; Department of Pharmaceutics, Virginia Commonwealth University, Richmond, VA 23298, USA; Department of Ophthalmology, Department of Biomedical Engineering, Department of Pediatrics, Center for Pharmaceutical Engineering, Center for Drug Discovery, and Massey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298, USA. Electronic address: qxu@vcu.edu.
Source: Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2026 May 10; Vol. 393, pp. 114793. Date of Electronic Publication: 2026 Mar 04.
Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
Journal Info: Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 8607908 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4995 (Electronic) Linking ISSN: 01683659 NLM ISO Abbreviation: J Control Release Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41791460
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A systematic approach to develop and characterize a compositionally equivalent buprenorphine in situ forming implant (Sublocade®).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Poudel+S%22">Poudel S</searchLink>; Department of Pharmaceutics, Virginia Commonwealth University, Richmond, VA 23298, USA.<br /><searchLink fieldCode="AU" term="%22Pangeni+R%22">Pangeni R</searchLink>; Department of Pharmaceutics, Virginia Commonwealth University, Richmond, VA 23298, USA.<br /><searchLink fieldCode="AU" term="%22Huo+Z%22">Huo Z</searchLink>; Department of Chemical engineering, Virginia Polytechnic Institute and State University, Blacksburg, VA 24061, USA.<br /><searchLink fieldCode="AU" term="%22Farkas+D%22">Farkas D</searchLink>; Department of Mechanical and Nuclear Engineering, Virginia Commonwealth University, Richmond, VA 23220, USA.<br /><searchLink fieldCode="AU" term="%22Gulec+S%22">Gulec S</searchLink>; Materials Characterization, Anton Paar Inc., Richmond, VA 23298, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+Q%22">Zhang Q</searchLink>; Office of Research and Standards, Office of Generic Drugs, CDER, U.S. Food and Drug Administration, Silver Springs, MD 20993, USA.<br /><searchLink fieldCode="AU" term="%22Lasaosa+M%22">Lasaosa M</searchLink>; Department of Pharmaceutics, Virginia Commonwealth University, Richmond, VA 23298, USA.<br /><searchLink fieldCode="AU" term="%22Tong+R%22">Tong R</searchLink>; Department of Chemical engineering, Virginia Polytechnic Institute and State University, Blacksburg, VA 24061, USA.<br /><searchLink fieldCode="AU" term="%22Moeller+FG%22">Moeller FG</searchLink>; Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA 23298, USA.<br /><searchLink fieldCode="AU" term="%22Li+Q%22">Li Q</searchLink>; Office of Research and Standards, Office of Generic Drugs, CDER, U.S. Food and Drug Administration, Silver Springs, MD 20993, USA.<br /><searchLink fieldCode="AU" term="%22Wang+Y%22">Wang Y</searchLink>; Office of Research and Standards, Office of Generic Drugs, CDER, U.S. Food and Drug Administration, Silver Springs, MD 20993, USA.<br /><searchLink fieldCode="AU" term="%22Qin+B%22">Qin B</searchLink>; Office of Research and Standards, Office of Generic Drugs, CDER, U.S. Food and Drug Administration, Silver Springs, MD 20993, USA.<br /><searchLink fieldCode="AU" term="%22Halquist+MS%22">Halquist MS</searchLink>; Department of Pharmaceutics, Virginia Commonwealth University, Richmond, VA 23298, USA.<br /><searchLink fieldCode="AU" term="%22Xu+Q%22">Xu Q</searchLink>; Department of Pharmaceutics, Virginia Commonwealth University, Richmond, VA 23298, USA; Department of Ophthalmology, Department of Biomedical Engineering, Department of Pediatrics, Center for Pharmaceutical Engineering, Center for Drug Discovery, and Massey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298, USA. Electronic address: qxu@vcu.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228607908%22">Journal of controlled release : official journal of the Controlled Release Society</searchLink> [J Control Release] 2026 May 10; Vol. 393, pp. 114793. <i>Date of Electronic Publication: </i>2026 Mar 04.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+Publishers%22">Elsevier Science Publishers </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8607908 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-4995 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201683659%22">01683659 </searchLink><i>NLM ISO Abbreviation: </i>J Control Release <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41791460
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.jconrel.2026.114793
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 114793
    Titles:
      – TitleFull: A systematic approach to develop and characterize a compositionally equivalent buprenorphine in situ forming implant (Sublocade®).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Poudel S
      – PersonEntity:
          Name:
            NameFull: Pangeni R
      – PersonEntity:
          Name:
            NameFull: Huo Z
      – PersonEntity:
          Name:
            NameFull: Farkas D
      – PersonEntity:
          Name:
            NameFull: Gulec S
      – PersonEntity:
          Name:
            NameFull: Zhang Q
      – PersonEntity:
          Name:
            NameFull: Lasaosa M
      – PersonEntity:
          Name:
            NameFull: Tong R
      – PersonEntity:
          Name:
            NameFull: Moeller FG
      – PersonEntity:
          Name:
            NameFull: Li Q
      – PersonEntity:
          Name:
            NameFull: Wang Y
      – PersonEntity:
          Name:
            NameFull: Qin B
      – PersonEntity:
          Name:
            NameFull: Halquist MS
      – PersonEntity:
          Name:
            NameFull: Xu Q
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 10
              M: 05
              Text: 2026 May 10
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1873-4995
          Numbering:
            – Type: volume
              Value: 393
          Titles:
            – TitleFull: Journal of controlled release : official journal of the Controlled Release Society
              Type: main
ResultId 1